Filter Results :

Your search for Neural returned 42 reports

Sort by


Neuralstem Inc (CUR) - Medical Equipment - Deals and Alliances Profile

22 Dec 2017  |  Published by:  GlobalData
SummaryNeuralstem Inc (Neuralstem) is a developer of medicines for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer's disease, traumatic brain injury, peripheral nerve injury, diabetic neuro...

$ 250.00

Read More

Neuraltus Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 Nov 2017  |  Published by:  GlobalData
SummaryNeuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. Neuraltus' focuses on macrophage which ...

$ 250.00

Read More

Hearing Aids Market by Product (Receiver In The Ear, Behind The Ear, In The Ear, In The Canal Hearing Aids, Cochlear Implant, BAHA implant), Types of Hearing Loss (Sensorineural, Conductive Hearing loss) & Patient (Adult, Pediatric) - Forecast to 2022

06 Nov 2017  |  Published by:  MarketsandMarkets
Global hearing aids market projected to grow at a CAGR of 7.0%The hearing aids market is expected to reach USD 9.78 billion by 2022 from USD 6.97 billion in 2017, at a CAGR of 7.0%. The high prevalence of hearing loss, rising geriatric population, and technological advancements in hearing aids are d...

$ 5,650.00

Read More

Postherpetic Neuralgia - Pipeline Insight, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “Postherpetic Neuralgia-Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Postherpetic Neuralgia. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and ...

$ 1,250.00

Read More

Postherpetic Neuralgia - Epidemiology Insights to 2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Postherpetic Neuralgia -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Postherpetic Neuralgia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Postherpetic Ne...

$ 2,950.00

Read More

Postherpetic Neuralgia - Market Insights, Epidemiology and Market Forecast -2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Postherpetic Neuralgia - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Postherpetic Neuralgia for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from...

$ 5,750.00

Read More

Postherpetic Neuralgia - Epidemiology Forecast To 2023

01 Nov 2017  |  Published by:  DelveInsight
Postherpetic Neuralgia - Epidemiology Forecast To 2023¯ provides an overview of the epidemiology trends of Postherpetic Neuralgia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Postherpetic Neuralgia preva...

$ 2,750.00

Read More

Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Postherpetic Neuralgia. The report includes information of marketed products including their product d...

$ 2,000.00

Read More

Neuralgia-Pipeline Insights, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “ Neuralgia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Neuralgia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, ...

$ 1,250.00

Read More

Acute Sensorineural Hearing Loss-Pipeline Insights, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “ Acute Sensorineural Hearing Loss-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Acute Sensorineural Hearing Loss. The DelveInsight’sReport covers the product profiles in various stages of development inc...

$ 1,250.00

Read More

Postherpetic Neuralgia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Nov 2017  |  Published by:  DelveInsight
Summary'Postherpetic Neuralgia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API ...

$ 2,000.00

Read More

Global Neuralgia Partnering 2010-2017

01 Nov 2017  |  Published by:  CurrentPartnering
The Global Neuralgia Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sec...

$ 1,495.00

Read More

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21.) - Pipeline Review, H2 2017

10 Oct 2017  |  Published by:  Global Markets Direct
SummaryProprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21.) pipeline Target constitutes close to 28 molecules. Out of which approximately 26 molecules are developed by companies...

$ 3,500.00

Read More

Latin America, Middle East & Africa Neural Network Market (2017 - 2023)

18 Aug 2017  |  Published by:  KBV Research
The Latin America, Middle East and Africa Neural Network Market is expected to register a CAGR of 35.3% during the forecast period (2017 – 2023). Neural Network Market encompasses a wide range of practices, tools, solutions, and techniques interrelated closely to a system of hardware and software. T...

$ 1,500.00

Read More

Asia Pacific Neural Network Market (2017 - 2023)

18 Aug 2017  |  Published by:  KBV Research
The Asia Pacific Neural Network Market is expected to register a CAGR of 33.1% during the forecast period (2017 – 2023). Neural networks are widely used in weather forecasting, handwriting recognition, oil-exploration data analysis, facial recognition, speech-to-text transcription, and others. With ...

$ 1,500.00

Read More
Total 42 records.